trial

Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders

NCTId NCT06423651
as of 2026-07-01
at a glance
· Unknown
Enrollment 160 (estimated)
Primary completion 2024-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Unknown
Enrollment
160 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2022-09-01
Primary completion
2024-12-31
Eligibility
ALL · 16 Years · 55 Years

Interventions & indications

Sponsors

Investigators

1
Ana Barajas VelezPrincipal Investigator

Sites

1 total
Cerdanyola del Vallès, Spain

Facts & assertions

4 sourced
Enrollment
160
Phase
NA
Primary Completion Date
2024-12-31
Status
UNKNOWN